Table 2 Biochemical results, coronary characteristics and clinical outcomes of patients
Parameter | Entire cohort (n = 295) | Low Lp(a) group (n = 148) | High Lp(a) group (n = 147) | P |
|---|---|---|---|---|
Laboratory values | ||||
 Platelet count, × 109/L (n = 295) | 224(184, 262) | 216(180, 257) | 233(187, 275) | 0.038 |
 hsCRP, mg/L (n = 272) | 1.57(0.65, 3.72) | 1.34(0.62, 2.99) | 1.85(0.70, 5.76) | 0.012 |
 eGFR, ml/min/1.73m2 (n = 295) | 87.50 ± 20.03 | 89.09 ± 19.87 | 85.91 ± 20.13 | 0.174 |
 TC, mmol/L (n = 295) | 3.82(3.22, 4.46) | 3.71(3.13, 4.40) | 3.88(3.42, 4.56) | 0.029 |
 LDL-c, mmol/L (n = 295) | 2.26(1.76, 2.86) | 2.18(1.61, 2.94) | 2.29(1.86, 2.82) | 0.174 |
 HDL-c, mmol/L (n = 295) | 1.06(0.90, 1.26) | 1.04(0.88, 1.22) | 1.11(0.92, 1.29) | 0.168 |
 Triglycerides, mmol/L (n = 295) | 1.49(1.08, 2.00) | 1.53(1.10, 2.20) | 1.40(1.06, 1.83) | 0.037 |
Coronary characteristics | ||||
 Presence of plaque, % (n = 293) | 289(98.6) | 144(98) | 145(99.3) | 0.619 |
Culprit vessel (n = 293) | ||||
 LAD, % | 253(86.3) | 130(88.4) | 123(84.2) | 0.296 |
 LCX, % | 199(67.9) | 100(68.0) | 99(67.8) | 0.968 |
 RCA, % | 213(72.7) | 99(67.3) | 114(78.1) | 0.039 |
 LM, % | 45(15.4) | 27(18.4) | 18(12.3) | 0.152 |
No. of diseased vessels (n = 293) | ||||
 1, % | 65(22.2) | 33(22.4) | 32(21.9) | 0.913 |
 2, % | 72(24.6) | 37(25.2) | 35(24.0) | 0.812 |
 3, % | 152(51.9) | 74(50.3) | 78(53.4) | 0.597 |
Target lesion morphology | ||||
 Bifurcation lesion, % (n = 175) | 22(12.6) | 8(9.5) | 14(15.4) | 0.243 |
 Chronic total occlusion, % (n = 175) | 46(26.3) | 20(23.8) | 26(28.6) | 0.475 |
 Complex lesion (lesion of type B2 or C), % (n = 175) | 140(80) | 63(75) | 77(84.6) | 0.112 |
 PCI, % (n = 295) | 172(58.3) | 82(55.4) | 90(61.2) | 0.311 |
Framingham risk score for estimation of 10-years of cardiovascular diseases risk | ||||
 Low-risk, % (n = 295) | 46(15.6) | 23(15.5) | 23(15.6) | 0.980 |
 Moderate-risk, % (n = 295) | 28(9.5) | 13(8.8) | 15(10.2) | 0.677 |
 High-risk, % (n = 295) | 221(74.9) | 112(75.7) | 109(74.1) | 0.762 |
 CABG, % (n = 295) | 22(7.5) | 12(8.1) | 10(6.8) | 0.670 |
 Follow-up time, months (n = 280) | 36(20, 52) | 35(21.75, 50.25) | 37(18.75, 53) | 0.847 |
 All-cause death, % (n = 280) | 10(3.6) | 3(2.1) | 7(5.1) | 0.311 |
 Rehospitalization, % (n = 280) | 12(4.3) | 3(2.1) | 9(6.5) | 0.069 |